CEL-SCI Corporation (CVM) Stock Forecast

NYSE American: CVMAnalyst ratings, price target and estimates.

CVM analyst forecast

as of October 17, 2026
Analyst consensus
Strong buy
5.00 / 5 from 1 analysts
Price target
$12.50
average of analyst targets
Upside to target
+598.3%
from the latest close
Next earnings
—
52-week range
$0.97 – $9.27

CVM analyst ratings

1 analysts
Strong buy
1100%
Buy
00%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

CVM price target

Price $1.79Target $12.50
52-week low $0.9752-week high $9.27

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

CVM earnings per share estimates

CEL-SCI Corporation EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current fiscal year (FY2026)−$3.07−$3.07−$3.07−$6.27+51.0%1
Next fiscal year (FY2027)−$6.38−$6.38−$6.38−$3.07−107.8%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

CVM revenue estimates

CEL-SCI Corporation revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current fiscal year (FY2026)$0$0$00.0%1
Next fiscal year (FY2027)$6.0M$6.0M$6.0M0.0%1

CVM EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

CVM revenue: reported and forecast

Reported revenueEstimate (average; low–high)

CVM EPS estimate revisions

CEL-SCI Corporation EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current fiscal year (FY2026)−$4.16$0.00$0.00$0.00−$3.07−26.2%0 up · 1 down
Next fiscal year (FY2027)$0.00$0.00$0.00$0.00−$6.38—0 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

CVM earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; CVM beat in 3 of 8.

What analysts expect from CVM

1 analysts cover CEL-SCI; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.50, 598.3% above the latest close of $1.79. Analysts expect earnings of −$3.07 per share for FY2026, +51.0% from a year earlier. For FY2027 the average estimate is −$6.38 per share on revenue of $6.0 million. CEL-SCI beat the EPS estimate in 3 of the last 8 quarters.

Related: CVM income statement, CVM key metrics, CVM chart. See the CVM stock overview for the latest quote and news.

CVM forecast FAQ

What is CEL-SCI's price target?

The average analyst price target for CEL-SCI is $12.50, 598.3% above the latest close of $1.79.

Is CEL-SCI a buy, hold or sell?

Of 1 analysts covering CEL-SCI, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is CEL-SCI's EPS forecast?

Analysts forecast −$3.07 per share for FY2026 (range −$3.07 to −$3.07); for FY2027 the estimate is −$6.38.

Does CEL-SCI usually beat earnings estimates?

CEL-SCI reported EPS at or above the analyst estimate in 3 of the last 8 quarters.

Biotechnology: forecast